» Articles » PMID: 28667380

Variants in the Non-coding Region of the TLR2 Gene Associated with Infectious Subphenotypes in Pediatric Sickle Cell Anemia

Overview
Journal Immunogenetics
Date 2017 Jul 2
PMID 28667380
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Sickle cell anemia (SCA) is characterized by chronic hemolysis, severe vasoocclusive crises (VOCs), and recurrent often severe infections. A cohort of 95 SCA pediatric patients was the background for genotype-to-phenotype association of the patient's infectious disease phenotype and three non-coding polymorphic regions of the TLR2 gene, the -196 to -174 indel, SNP rs4696480, and a (GT)n short tandem repeat. The infectious subphenotypes included (A) recurrent respiratory infections and (B) severe bacterial infection at least once during the patient's follow-up. The absence of the haplotype [Del]-T-[n ≥ 17] (Hap7) in homozygocity protected against subphenotype (B), in a statistically significant association, resisting correction for multiple testing. For the individual loci, the same association tendencies were observed as in the haplotype, including a deleterious association between the SNP rs4696480 T allele and subphenotype (A), whereas the A/A genotype was protective, and a deleterious effect of the A/T genotype with subphenotype (B), as well as including the protective effect of -196 to -174 insert (Ins) and deleterious effect of the deletion (Del) in homozygocity, against subphenotype (B). Moreover, a reduction in the incidence rate of severe bacterial infection was associated to a rise in the hemolytic score, fetal hemoglobin levels (prior to hydroxyurea treatment), and 3.7-kb alpha-thalassemia. Interestingly, differences between the effects of the two latter covariables favoring a reduction in the incidence rate of subphenotype (B) contrast with a resulting increase in relation to subphenotype (A). These results could have practical implications in health care strategies to lower the morbidity and mortality of SCA patients.

Citing Articles

Plasma free hemoglobin is associated with LDH, AST, total bilirubin, reticulocyte count, and the hemolysis score in patients with sickle cell anemia.

Liu A, Jacobs-McFarlane C, Sebastiani P, Glassberg J, McCuskee S, Curtis S Ann Hematol. 2025; .

PMID: 39969536 DOI: 10.1007/s00277-025-06253-w.


Inflammatory pathways and anti-inflammatory therapies in sickle cell disease.

Tozatto-Maio K, Ros F, Weinlich R, Rocha V Hemasphere. 2024; 8(12):e70032.

PMID: 39698332 PMC: 11655128. DOI: 10.1002/hem3.70032.


Plasma free hemoglobin is associated with LDH, AST, total bilirubin, reticulocyte count, and the hemolysis score in patients with sickle cell anemia.

Liu A, Jacobs-McFarlane C, Sebastiani P, Glassberg J, McCuskee S, Curtis S Res Sq. 2024; .

PMID: 38746469 PMC: 11092852. DOI: 10.21203/rs.3.rs-4252554/v1.


Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.

Kirkham J, Estepp J, Weiss M, Rashkin S JAMA Netw Open. 2023; 6(10):e2337484.

PMID: 37851445 PMC: 10585422. DOI: 10.1001/jamanetworkopen.2023.37484.


Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease.

Tozatto-Maio K, Girot R, Ly I, Silva Pinto A, Rocha V, Fernandes F Front Immunol. 2020; 11:2041.

PMID: 33013863 PMC: 7510050. DOI: 10.3389/fimmu.2020.02041.

References
1.
Ver Hoef J, Boveng P . Quasi-Poisson vs. negative binomial regression: how should we model overdispersed count data?. Ecology. 2007; 88(11):2766-72. DOI: 10.1890/07-0043.1. View

2.
ONeill L, Bryant C, Doyle S . Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev. 2009; 61(2):177-97. PMC: 2846156. DOI: 10.1124/pr.109.001073. View

3.
Bridges K, Barabino G, Brugnara C, Cho M, Christoph G, Dover G . A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood. 1996; 88(12):4701-10. View

4.
Wu Q, Chu H . Role of infections in the induction and development of asthma: genetic and inflammatory drivers. Expert Rev Clin Immunol. 2009; 5(1):97-109. PMC: 2718769. DOI: 10.1586/1744666X.5.1.97. View

5.
Kawai T, Akira S . Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011; 34(5):637-50. DOI: 10.1016/j.immuni.2011.05.006. View